☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Risk of Hospitalization
AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Approval for Reducing the Risk of Hospitalization for Heart Failure in...
October 21, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.